Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2100052350Phase 4Not yet recruiting
Phase 4, randomised trial of butorphanol in lung neoplasm (2 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoints: Mini-Mental State Examination (MMSE), Visual Analog Scale (VAS) pain score and 1 more. Planned start Oct 2021; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2100052350.